Sonoma Pharmaceuticals Inc (SNOA)
0.16
0.00 (0.00%)
USD |
NASDAQ |
Apr 24, 16:00
0.1652
+0.01
(+3.25%)
After-Hours: 20:00
Sonoma Pharmaceuticals Revenue (TTM): 12.31M for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 12.31M |
| September 30, 2023 | 12.12M |
| June 30, 2023 | 12.72M |
| March 31, 2023 | 13.27M |
| December 31, 2022 | 12.56M |
| September 30, 2022 | 12.51M |
| June 30, 2022 | 12.93M |
| March 31, 2022 | 12.63M |
| December 31, 2021 | 12.49M |
| September 30, 2021 | 14.52M |
| June 30, 2021 | 16.55M |
| March 31, 2021 | 18.63M |
| December 31, 2020 | 20.78M |
| September 30, 2020 | 20.24M |
| June 30, 2020 | 19.20M |
| March 31, 2020 | 17.93M |
| December 31, 2019 | 18.00M |
| September 30, 2019 | 18.88M |
| June 30, 2019 | 19.10M |
| March 31, 2019 | 18.97M |
| December 31, 2018 | 18.24M |
| September 30, 2018 | 17.81M |
| June 30, 2018 | 17.19M |
| March 31, 2018 | 16.66M |
| December 31, 2017 | 17.03M |
| Date | Value |
|---|---|
| September 30, 2017 | 15.55M |
| June 30, 2017 | 14.02M |
| March 31, 2017 | 12.83M |
| December 31, 2016 | 11.37M |
| September 30, 2016 | 10.49M |
| June 30, 2016 | 11.75M |
| March 31, 2016 | 12.79M |
| December 31, 2015 | 14.20M |
| September 30, 2015 | 14.93M |
| June 30, 2015 | 14.14M |
| March 31, 2015 | 13.85M |
| December 31, 2014 | 12.79M |
| September 30, 2014 | 12.86M |
| June 30, 2014 | 13.69M |
| March 31, 2014 | 13.67M |
| December 31, 2013 | 14.09M |
| September 30, 2013 | 14.34M |
| June 30, 2013 | 14.77M |
| March 31, 2013 | 15.45M |
| December 31, 2012 | 15.47M |
| September 30, 2012 | 14.72M |
| June 30, 2012 | 13.86M |
| March 31, 2012 | 12.74M |
| December 31, 2011 | 12.10M |
| September 30, 2011 | 11.63M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
12.12M
Minimum
Sep 2023
20.78M
Maximum
Dec 2020
15.65M
Average
14.52M
Median
Sep 2021
Revenue (TTM) Benchmarks
| NovaBay Pharmaceuticals Inc | 14.73M |
| Palatin Technologies Inc | 7.098M |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
| Oragenics Inc | -- |